PMID: 7016982Mar 1, 1981Paper

A proteolytic procoagulant associated with malignant transformation

The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society
S G Gordon

Abstract

There is increased deposition and lysis of fibrin in cancer, but little is known about the causes of this abnormal fibrin formation. This article reviews research on cancer procoagulant and presents some preliminary immunohistochemical studies. Cancer procoagulant was purified from a rabbit V2 carcinoma. It was a single polypeptide cysteine protease with a molecular weight of 68,000 daltons and an isoelectric point of 4.8-4.9. It initiates coagulation by directly activating factor X within the coagulation cascade. Its physical, chemical, and enzymatic properties distinguish it from serine proteases within the coagulation cascade and suggest that it is a protein from neoplastic cells. To determine whether cancer procoagulant was unique to the malignant state, procoagulant activity was assayed in extracts of normal and malignant tissue and serum-free medium from normal and transformed fibroblasts. Normal tissue and cells had procoagulant activity with characteristics similar to tissue factor, while malignant tissue and transformed cells had a procoagulant with the characteristics of cancer procoagulant, suggesting that cancer procoagulant is unique to the malignant state. An antibody to cancer procoagulant was used for horseradis...Continue Reading

Citations

Jan 1, 1983·Cancer Metastasis Reviews·H F DvorakA M Dvorak
Sep 20, 1985·Biochimica Et Biophysica Acta·A Falanga, S G Gordon
Feb 13, 2007·Critical Reviews in Oncology/hematology·Jeffrey I ZwickerBruce Furie
Dec 15, 1986·International Journal of Cancer. Journal International Du Cancer·A C Wilson, M J Fasco
Oct 14, 2018·Cancers·Norbaini Binti Abdol RazakPat Metharom
Jan 1, 1983·Biochemical Pharmacology·K V HonnB F Sloane

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.